Medical Device | September 24, 2025
All drug substance for Moderna’s authorized Spikevax (COVID-19 mRNA vaccine) targeting the SARS-CoV-2 LP.8.1 variant is produced at the company’s facility in Laval, Quebec
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
Subscribe To Our Newsletter & Stay Updated
